Analisis firma tersebut menyoroti kekhawatiran mengenai sentimen pasar saat ini terhadap Merck, yang dipengaruhi oleh faktor-faktor seperti kinerja vaksin Gardasil dan perkembangan yang akan datang.

Selain itu, Merck telah terlibat dalam proses hukum mengenai vaksin Gardasil, yang menghasilkan putusan yang menguntungkan karena hakim menolak lebih dari 200 kasus terkait dugaan efek samping.

In what’s shaping up to be a red-letter week for Gardasil, Merck & Co. has simultaneously opened a massive new manufacturing facility for the human papillomavirus (HPV) shot in the U.S. and put ...

March 11 (Reuters) - A federal judge ruled in favor of Merck (MRK.N), opens new tab in litigation accusing it of concealing the risks of Gardasil, a vaccine to prevent cervical and other cancers ...

More than 200 lawsuits demand warnings on Gardasil labels about an autoimmune disease called Postural Orthostatic Tachycardia Syndrome, or POTS, and Primary Ovarian Insufficiency, or POI ...

(Reuters) -A federal judge ruled in favor of Merck (NSE:PROR) in litigation accusing it of concealing the risks of Gardasil, a vaccine to prevent cervical and other cancers caused by the human ...

A federal judge ruled in Merck & Co.’s favor in a safety lawsuit over its Gardasil vaccine, allowing the drugmaker to sidestep more than 200 cases claiming the company concealed safety risks.

A federal judge in North Carolina on Tuesday granted an order for summary judgment in favor of Merck (NYSE:MRK) regarding lawsuits accusing the drugmaker of failing to warn consumers its Gardasil ...

A federal judge ruled in favor of Merck in litigation accusing it of concealing the risks of Gardasil, a vaccine to prevent cervical and other cancers caused by the human papillomavirus and one of ...

U.S. District Judge Kenneth Bell ruled in Merck’s (MRK) favor in a safety lawsuit over the company’s Gardasil vaccine, allowing the pharma giant to sidestep over 200 complaints alleging the ...

This new plant will manufacture the HPV vaccines Gardasil and Gardasil 9, Merck told The News & Observer on Monday, while the site as a whole continues to produce vaccines against measles ...

At its sprawling complex in Durham, N.C., Merck has opened a new $1 billion, 225,000-square-foot manufacturing plant slated to produce bulk substance for its megablockbuster HPV vaccine Gardasil.